PMID- 32280716 OWN - NLM STAT- MEDLINE DCOM- 20210125 LR - 20210125 IS - 2314-6753 (Electronic) IS - 2314-6745 (Print) VI - 2020 DP - 2020 TI - Middle-Aged Indians with Type 2 Diabetes Are at Higher Risk of Biological Ageing with Special Reference to Serum CDKN2A. PG - 7569259 LID - 10.1155/2020/7569259 [doi] LID - 7569259 AB - Sedentary lifestyle and high visceral adiposity have elevated the risk of type 2 diabetes (T2DM) among Indians at younger age. In this study, we aimed to investigate the association of oxidative stress and chronic inflammatory mediators with ageing with special reference to the biological ageing marker cyclin-dependent kinase inhibitor 2A (CDKN2A) among middle-aged (31-50 years) Indian healthy and T2DM subjects. Malondialdehyde (MDA), oxidized LDL (oxLDL), interleukin-6 (IL-6), interleukin 1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1), and CDKN2A were measured in T2DM patients (n = 80) and controls (n = 80) aged 31-50 years, further grouped into G1: 31-40 years and G2: 41-50 years. IL-6, TNF-alpha, MCP-1, and CDKN2A showed a significant association with ageing among both T2DM patients and controls. But the strength of the association of MCP-1 and CKDN2A with ageing was significantly stronger in T2DM patients than the controls. All the oxidative stress and proinflammatory mediators showed nonsignificant associations with CDKN2A in the controls. However, IL-6, TNF-alpha, and MCP-1 showed a strong association with CDKN2A in T2DM patients. An increased risk of high levels of CDKN2A was found in G1 T2DM patients (OR: 3.484 (95% CI: 1.246-9.747) p = 0.017) and G2 T2DM patients (OR: 5.000 (95% CI: 1.914-13.061), p = 0.001) with reference to the respective control groups. Our study reveals that the middle-aged Indians with T2DM are at higher risk of biological ageing. The development of T2DM is more common among middle-aged Indians. T2DM may exacerbate the ageing process and may subsequently predispose Indians to various age-related complications at a much early age. CI - Copyright (c) 2020 Joyita Banerjee et al. FAU - Banerjee, Joyita AU - Banerjee J AUID- ORCID: 0000-0002-8756-0574 AD - Symbiosis School of Biological Sciences (Formerly Symbiosis School of Biomedical Sciences), Symbiosis International (Deemed University), Lavale, Pune, India. FAU - Dhas, Yogita AU - Dhas Y AUID- ORCID: 0000-0003-2566-8341 AD - Symbiosis School of Biological Sciences (Formerly Symbiosis School of Biomedical Sciences), Symbiosis International (Deemed University), Lavale, Pune, India. FAU - Mishra, Neetu AU - Mishra N AUID- ORCID: 0000-0002-0526-2056 AD - Symbiosis School of Biological Sciences (Formerly Symbiosis School of Biomedical Sciences), Symbiosis International (Deemed University), Lavale, Pune, India. LA - eng PT - Journal Article DEP - 20200323 PL - England TA - J Diabetes Res JT - Journal of diabetes research JID - 101605237 RN - 0 (Biomarkers) RN - 0 (CDKN2A protein, human) RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Adult MH - Aging/*blood MH - Biomarkers/blood MH - Cyclin-Dependent Kinase Inhibitor p16/*blood MH - Diabetes Mellitus, Type 2/*blood MH - Female MH - Humans MH - India MH - Interleukin-6/blood MH - Male MH - Middle Aged MH - Tumor Necrosis Factor-alpha/blood PMC - PMC7128035 COIS- The authors declare that there is no conflict of interest regarding the publication of this paper. EDAT- 2020/04/14 06:00 MHDA- 2021/01/26 06:00 PMCR- 2020/03/23 CRDT- 2020/04/14 06:00 PHST- 2019/09/23 00:00 [received] PHST- 2020/03/04 00:00 [accepted] PHST- 2020/04/14 06:00 [entrez] PHST- 2020/04/14 06:00 [pubmed] PHST- 2021/01/26 06:00 [medline] PHST- 2020/03/23 00:00 [pmc-release] AID - 10.1155/2020/7569259 [doi] PST - epublish SO - J Diabetes Res. 2020 Mar 23;2020:7569259. doi: 10.1155/2020/7569259. eCollection 2020.